MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new Aptima ® BV and Aptima ® CV/TV assays, which provide an accurate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results